Clinical trial
A Study of Respiratory Muscle Strength, Including Effort-Independent Measures, in Subjects With Late-Onset Pompe Disease
NCT02191917 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Respiratory Muscle Strength, Including Effort-Independent Measures, in Subjects With Late-Onset Pompe Disease
- Lead sponsor
- BioMarin Pharmaceutical
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 21, 2014
- Completion date
- June 22, 2016
- Enrollment
- 8 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
late-onset pompe disease